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Abstract: We investigated the characteristics of lymphocytes propagated 
from biopsies of the mesenteric lymph nodes, liver, and ileum of a 
human multivisceral allograft in order to provide functional evidence for 
the presence or absence of rejection and graft-versus-host disease (GYHD). 
The recipient was a 39-month-old girl with secretory diarrhea due to 
microvillus inclusion disease and end-stage liver disease secondary to pro-
longed parenteral nutrition. She developed a multifocal posttransplant 
lymphoproliferative disorder (PTLD) and died 37 days after transplan-
tation. Four pairs of sequential mesenteric lymph node and liver biopsies 
(13, 17, 24, and 33 d posttransplant) and a single ileal biopsy (31 d 
posttransplant) were placed in culture with recombinant interleukin-2 
(rIL-2) and phytohemagglutinin (PHA). T-cell phenotyping of cultured 
cells showed that CD8+cells became dominant in all three tissues. The 
alloreactivity of biopsy-grown cells was determined using the primed 
lymphocyte test (PLT) and cell-mediated lympholysis test (CML). The 
proliferative and/or cytolytic responses of biopsy-grown cells to donor but 
not recipient or third party cells provided evidence for rejection and 
absence of GYHD. This donor-specific alloreactivity was detected before 
there was histologic evidence of rejection and during the period of active 
lymphoproliferation. This study suggests that the functional character-
ization of graft-infiltrating lymphocytes is useful in defining the immuno-
logic events following multivisceral transplantation. 
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Human multivisceral transplantation has been re-
ported so far in only 5 children whose own small 
intestines were missing or irreversibly damaged and 
who had secondary liver disease due to prolonged 
intravenous feeding (1-3). Because of this limited 
experience, the clinical and pathologic criteria for 
the diagnosis of multivisceral graft dysfunction are 
not yet well established. 
However, such studies cannot determine the actual 
function of lymphoid cells detected in graft bi-
opSIes. 
Several immunologic processes may potentially 
jeopardize the function of a multivisceral graft, 
including rejection, GVHD and lymphoprolifer-
ation. Morphologic monitoring remains the gold-
standard for diagnosing these processes in heart, 
liver, and kidney recipients and was used to moni-
tor the first 3 relatively long-surviving pediatric 
multi visceral recipients (192, 109, and 37 d) (1-3). 
This work was supported by Grants AI-23467 and HL-36416 
from the National Institutes of Health and by the Pathology 
Education and Research Foundation. 
In vitro studies of cells propagated from trans-
plant biopsies have provided important infor-
mation about the function of cells involved in graft 
rejection. These cells can be expanded in the pres-
ence of IL-2, a lymphokine that induces prolifer-
ation of activated T cells, and tested for donor-
specific alloreactivity in secondary proliferation 
and cell-mediated cytotoxicity assays (4-7). We 
have used these methods to analyze the character-
istics of lymphocytes propagated from allograft 
biopsies of the mesenteric lymph nodes, liver, and 
ileum from a child with a multivisceral transplant. 
The studies were carried out to supplement the 
pathological analysis of graft biopsies which was 
complicated by the lack of prior relevant experi-
ence in human multivisceral transplantation (3). 
Specifically, we wanted to determine if the graft 
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contained donor-reactive cells mediating rejection, 
host-reactive cells mediating GVHD, or both. We 
were also interested in correlating the functional 
studies of biopsy-grown cells with the pathologic 
findings in graft biopsies. 
Methods 
Patient 
The patient (HLA A24,32; B27,-; Bw4,6; DR5,6; 
DRw52; DQwI,3) was a 39-month-old Navajo girl 
with secretory diarrhea since birth due to microvil-
lus inclusion disease and end-stage liver disease 
secondary to prolonged parenteral feeding. On N 0-
vember 29, 1988, she received a liver, pancreas, 
partial stomach, small bowel, and colon transplant. 
The donor (HLA A2,28; B27,35; Bw4,6; DRw6; 
DQwI) was an 18-month-old male who suffered a 
lethal head injury 7 1/2 hours before organ re-
moval. The donor organs were pretreated with 
OKT3 to prevent GVHD. Preservation was by the 
"slush technique" after infusion with UW solution 
(1, 8) and the cold ischemia time from removal of 
the organs was 6 h. The operative details have been 
reported elsewhere (3). 
Immunosuppression consisted of cyclosporine, 
azathioprine, steroids, and rabbit antithymocyte 
globulin. In addition, a 2-wk course of OKT3 was 
started on postoperative d 18 for treatment of a 
clinical rejection episode which was confirmed by 
liver, stomach, and ileal biopsies taken on post-
operative d 24 (3). On the 33rd postoperative d, a 
muitifocal polyclonal Epstein-Barr virus-associ-
ated PTLD (9) was diagnosed (3). A capillary leak 
syndrome and progressive renal failure developed 
making fluid balance impossible. The patient died 
on 6 January 1989, 37 d after transplantation. 
Biopsies and lymphocyte propagation 
Four sequential pairs of mesenteric lymph node 
(LNI through LN4) and liver (LBxl through 
LBx4) biopsies were taken on postoperative d 13, 
17,24, and 33 during diagnostic laparotomies and 
an ileal biopsy was taken on postoperative d 31 
through an ileostomy. As described previously (5), 
biopsies were placed into tissue culture medium 
(TCM) containing 30 U /ml rIL-2. Ileal biopsies 
were pretreated for 30 min with TCM containing 
0.24 )lg/ml Fungizone (Gibco Laboratories, Grand 
Island, NY). PHA (0.1 mg/ml) (Difco Laborato-
ries, Detroit, MI) was initially added to all cultures. 
After 5-15 d of growth, cells were characterized by 
phenotypic and functional analysis. 
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Phenotyping 
Phenotyping of liver- and ileum-derived lympho-
cytes was done by indirect immunoperoxidase 
staining of cytospins of cultured cells with anti-
CD4 (helper/inducer T cell), anti-CD8 (suppressor/ 
cytotoxic T cell) and anti-CD2 (pan T cell) mono-
clonal antibodies (Dako Corporation, Santa Bar-
bara, CA). The mean of triplicate counts of 300 
consecutive cells was used to calculate the percent 
positively staining cells. Phenotyping of cultured 
lymph node-derived lymphocytes was performed 
on a flow cytometer (FACScan, Becton Dickinson, 
Mountain View, CA). 
Functional testing 
Functional testing of cultured lymphocytes was 
performed using the PLT and the CML, both pre-
viously described (5). Briefly, PLT reactivity of 
lymphocyte cultures was measured in 3-d prolifer-
ation assays. Stimulator cells were irradiated (2000 
rad) donor lymph node lymphocytes and recipient 
and third party peripheral blood lymphocytes 
(PBL). In addition, proliferation to rIL-2 and 
spontaneous proliferation in 10% human AB 
serum (media) was assessed. Proliferation was 
measured by incorporation of3H-thymidine. CML 
reactivity of lymphocyte cultures was measured in 
4-h slCr release assays. Targets were PHA blasts 
derived from donor lymph node lymphocytes and 
recipient PBL. Effector: target ratios varied from 
2: 1 to 20: 1 depending on the amount of effector 
cells available. The % CML was calculated from 
the formula: 
%CML= 
experimental release - background release 1 ~~--------------~---------x 00 
total release - background release 
RlsuHs 
The phenotype and PLT and CML reactivity of 
lymphocyte cultures propagated from biopsy ma-
terial is shown in Table 1. Also shown are the 
histologic diagnoses of nearby mesenteric lymph 
node, liver, and ileal biopsies taken during the same 
diagnostic procedures. 
Cultured cells were 90-99% CD2+.Cells grown 
from the mesenteric lymph node biopsies were pre-
dominantly CD8 + and demonstrated donor PLT 
reactivity in early biopsies followed by a loss in 
reactivity with successive biopsies. In contrast, do-
nor CML reactivity was positive with each biopsy. 
The complete loss of donor PLT reactivity in 
lymphocyte cultures propagated from LN3 and 
LN4 may have been related to the 2-wk administra-
tion of OKT3 beginning on postoperative d 18 for 
treatment of rejection. The most striking histologic 
feature of nearby lymph node biopsies taken at the 
same time as LNl, LN2, and LN3 was paracortical 
hyperplasia (3). Immunohistochemical staining 
demonstrated that the paracortical hyperplasia was 
due to a proliferation of T cells and monoclonal 
antibody staining for donor (HLA A2) and reci-
pient (HLA A24) class I antigens showed that the 
proliferating T cells were of recipient origin (3). 
It is likely that this recipient T-cell hyperplasia 
reflected donor-specific proliferation as suggested 
by positive PLT and/or CML responses oflympho-
cytes propagated from LNl, LN2, and LN3. The 
specificity of the PLT responses was confirmed by 
the lack of proliferation to third party PBL. 
A nearby mesenteric lymph node biopsy taken 
at the same time as LN4 did not show paracortical 
hyperplasia but a polyclonal B-celllymphoprolifer-
ation of recipient origin (3). Cells grown from LN4 
exhibited donor cytotoxicity. This indicates that 
LN4 initially contained donor-reactive cytotoxic 
cells within the population of proliferating B cells. 
The presence of B cells within LN4 itself was con-
firmed by flow cytometry of an early (3-d) culture 
of LN4 which showed 29% B cells and 51 % T 
cells. With time these B cells were lost from culture 
due to the lack of a stimulus for B-cell prolifer-
ation. 
Liver biopsy-grown cells initially showed a high 
CD4:CD8 ratio, but this ratio decreased with each 
successive biopsy so that cells grown from the 
fourth biopsy were mainly CD8 +. The donor PLT 
reactivity of cells grown from the sequential liver 
biopsies was similar to that of cells grown from 
Multivisceral transplantation 
the sequential lymph node biopsies, with high reac-
tivity early on, followed by a decline in reactivity 
during OKT3 treatment. Third party PLT re-
sponses were also negative. Donor CML reactivity 
was present in all liver biopsy cultures. It is import-
ant to note that, while donor-reactive cells were 
grown from LBxl and LBx2, samples of nearby 
liver tissue taken at the same time as these biopsies 
showed infiltrating cells but no clear-cut evidence 
of rejection (3). While these differences may have 
been caused by sampling errors, it is more likely 
that the functional studies were able to detect rejec-
tion earlier than histologic examination. Indeed, 
histologic evaluation of a liver biopsy taken at the 
same time as LBx3 showed partially-treated acute 
cellular rejection (3), indicating that rejection had 
started before this biopsy was taken. 
Cells grown from the ileal biopsy, taken at the 
end of OKT3 treatment, were mainly CD8+and 
exhibited donor cytotoxicity. A nearby biopsy of 
the ileum taken at the same time showed a clear 
histologic picture of rejection (3). 
An important clinical concern was the possible 
development of GVHD mediated by donor-derived 
lymphocytes reactive toward the recipient (1, 10). 
As a measure of graft-versus-host reactivity of bio-
psy-grown cells, we used recipient PBL as stimu-
lators in PLT assays and as targets in CML assays. 
Biopsy-grown cells were not able to proliferate in 
response to, or to kill, recipient PBL, indicating 
absence of sensitization to recipient PBL. This is 
consistent with the histologic evidence for absence 
of GVHD which included a determination of the 
donor/recipient origin of cells infiltrating the allo-
graft mesenteric lymph nodes, ileum, and colon 
and the native colon and skin (3). The donor sites 
showed infiltrating cells only of recipient origin 
Table 1. Phenotype and reactivity of lymphocyte cultures propagated from allograft mesenteric lymph node (LN), liver (LBx) and ileal biopsies and histologic 
diagnoses of nearby biopsies 
Phenotype PLl" CML' 
Post op Third Patient Donor 
Biopsy day %CD2+ %CD4+ %CD8+ Media Patient party Donor IL-2 (E:"P') (E:1") Histologic Diagnosis 
LN1 13 99 22 69 192 154 1986 18352 39768 1 (16:1) 16 (10:1) Paracortical hyperplasia 
LN2 17 99 3 91 440 233 1283 2879 60904 o (16:1) 54 (2.5:1) Paracortical hyperplasia 
LN3 24 95 32 63 204 1913 1480 266 35124 0(8:1) 16 (8:1) Paracortical hyperplasia 
LN4 33 90 5 83 16071d n.t.' 17041 17965 46509 1 (20:1) 23 (10:1) Lymphoproliferation 
LBx1 13 97 82 15 131 358 986 17857 30059 0(5:1) 30 (2:1) Cholangitis 
LBx2 17 92 41 52 175 172 1286 ORO~ 45455 0(10:1) 27 (4:1) Pericholangitis 
LBx3 24 97 25 58 280 473 1003 1802 26945 0(5:1) 54 (5:1) Partially-treated rejection 
LBx4 33 96 9 89 1375d n.t8 1613 2218 21662 0(5:1) 15 (5:1) Lymphoproliferation 
Ileum 31 97 27 62 4054 1548 4757 7628 47845 0(5:1) 26 (5:1) Rejection 
'PLT = primed lymphocyte test; CML = cell-mediated Iympholysis test; PLT results expressed as mean counts per minute of triplicate wells; CML results 
expressed as percent cytotoxicity of triplicate wells; S.U < 15%. bHighest effect: target ratio used. 'Lowest effect: target ratio yielding a positive CML. dHigh 
background due to short-term culture (5 days). 8n.t. = not tested. 
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and the recipient sites showed no infiltrating cells 
of donor origin. 
Discussion 
Human multivisceral transplantation is a relatively 
new procedure; therefore, the clinical and patho-
logic spectrum of graft dysfunction has yet to be 
established. Although detailed pathologic studies 
of graft biopsies from the presently described pa-
tient indicated the occurrence of rejection and lym-
phoproliferation and absence of GVHD (3), the 
diagnosis of these processes was complicated by 
the lack of relevant experience in this area. It was 
thus important to incorporate other methods of 
investigating the pathologic events occurring 
within the graft. 
We performed functional tests on lymphocytes 
propagated from mUltiple mesenteric lymph node 
and liver biopsies and a single ileal biopsy to deter-
mine if donor- and/or recipient-reactive cells were 
present in the graft. We were able to demonstrate 
donor, but not recipient, reactivity of the cultured 
cells in PLT and CML assays, a finding which 
reinforced the pathologic diagnosis of rejection and 
absence of GVHD. The specificity of the PLT re-
sponses was confirmed using third-party control 
lymphocytes. 
In addition, the functional studies highlighted 
other important intragraft events. First, the studies 
indicated that a dynamic process of cellular infil-
tration was occurring. During OKT3 treatment, 
there was a shift in the population of cells infiltra-
ting the mesenteric lymph nodes and liver from 
proliferative/cytolytic cells to cytolytic cells alone. 
What influence OKT3 had on this shift is not 
known. Second, the functional tests were able to 
detect donor-reactive cells within the liver before 
hepatic rejection was evident histologically (LBx 1 
and LBx2). This is similar to our previous obser-
vation that growth of donor-reactive cells from 
heart allograft biopsies showing no histologic evi-
dence of rejection was predictive of a subsequent 
rejection episode (11). Finally, the functional stud-
ies demonstrated that, histologically, lymphoproli-
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feration is able to mask rejection (LN4). This is the 
first pediatric multivisceral recipient to undergo 
simultaneous lymphoproliferation and rejection. 
Our studies suggest that the functional char-
acterization of graft-infiltrating lymphocytes 
should prove useful in the future delineation of 
human multivisceral transplant pathology. 
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